158 related articles for article (PubMed ID: 3066087)
1. Pancreatic B-cell function in relation to diabetic retinopathy in Asian Indian NIDDM patients.
Snehalatha C; Mohan R; Mohan V; Ramachandran A; Viswanathan M
Acta Diabetol Lat; 1988; 25(2):95-100. PubMed ID: 3066087
[TBL] [Abstract][Full Text] [Related]
2. Development and progression of diabetic retinopathy in Koreans with NIDDM.
Kim HK; Kim CH; Kim SW; Park JY; Hong SK; Yoon YH; Lee KU
Diabetes Care; 1998 Jan; 21(1):134-8. PubMed ID: 9538984
[TBL] [Abstract][Full Text] [Related]
3. High serum lipoprotein(a) levels in Korean type 2 diabetic patients with proliferative diabetic retinopathy.
Kim CH; Park HJ; Park JY; Hong SK; Yoon YH; Lee KU
Diabetes Care; 1998 Dec; 21(12):2149-51. PubMed ID: 9839109
[TBL] [Abstract][Full Text] [Related]
4. Slightly elevated blood pressure as well as poor metabolic control are risk factors for the progression of retinopathy in early-onset Japanese Type 2 diabetes.
Okudaira M; Yokoyama H; Otani T; Uchigata Y; Iwamoto Y
J Diabetes Complications; 2000; 14(5):281-7. PubMed ID: 11113692
[TBL] [Abstract][Full Text] [Related]
5. High prevalence of proliferative retinopathy in diabetic patients with low pancreatic B-cell capacity.
Suzuki K; Watanabe K; Motegi T; Kajinuma H
Diabetes Res Clin Pract; 1989 Jan; 6(1):45-52. PubMed ID: 2649341
[TBL] [Abstract][Full Text] [Related]
6. Clinical profile of lean NIDDM in South India.
Mohan V; Vijayaprabha R; Rema M; Premalatha G; Poongothai S; Deepa R; Bhatia E; Mackay IR; Zimmet P
Diabetes Res Clin Pract; 1997 Nov; 38(2):101-8. PubMed ID: 9483373
[TBL] [Abstract][Full Text] [Related]
7. Elevated serum levels of soluble vascular cell adhesion molecule-1 in NIDDM patients with proliferative diabetic retinopathy.
Yoshizawa M; Nagai Y; Ohsawa K; Ohta M; Yamashita H; Hisada A; Miyamoto I; Miura K; Takamura T; Kobayashi K
Diabetes Res Clin Pract; 1998 Oct; 42(1):65-70. PubMed ID: 9884035
[TBL] [Abstract][Full Text] [Related]
8. Clustering of albumin excretion rate abnormalities in Caucasian patients with NIDDM. The Italian NIDDM Nephropathy Study Group.
Faronato PP; Maioli M; Tonolo G; Brocco E; Noventa F; Piarulli F; Abaterusso C; Modena F; de Bigontina G; Velussi M; Inchiostro S; Santeusanio F; Bueti A; Nosadini R
Diabetologia; 1997 Jul; 40(7):816-23. PubMed ID: 9243103
[TBL] [Abstract][Full Text] [Related]
9. Diabetic retinopathy: contemporary prevalence in a well-controlled population.
Brown JB; Pedula KL; Summers KH
Diabetes Care; 2003 Sep; 26(9):2637-42. PubMed ID: 12941732
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of retinopathy in non insulin dependent diabetes mellitus at a diabetes centre in southern India.
Rema M; Ponnaiya M; Mohan V
Diabetes Res Clin Pract; 1996 Sep; 34(1):29-36. PubMed ID: 8968688
[TBL] [Abstract][Full Text] [Related]
11. Residual B cell function in patients with long-standing NIDDM and its relation to metabolic control and diabetic complications.
Iwase M; Kikuchi M; Nunoi K; Maki Y; Wakisaka M; Wada M; Fujishima M
Endocrinol Jpn; 1988 Dec; 35(6):803-8. PubMed ID: 3074917
[TBL] [Abstract][Full Text] [Related]
12. Beta 3-adrenoreceptor gene polymorphism: a newly identified risk factor for proliferative retinopathy in NIDDM patients.
Sakane N; Yoshida T; Yoshioka K; Nakamura Y; Umekawa T; Kogure A; Takakura Y; Kondo M
Diabetes; 1997 Oct; 46(10):1633-6. PubMed ID: 9313761
[TBL] [Abstract][Full Text] [Related]
13. Association of increased levels of MCP-1 and cathepsin-D in young onset type 2 diabetes patients (T2DM-Y) with severity of diabetic retinopathy.
Reddy S; Amutha A; Rajalakshmi R; Bhaskaran R; Monickaraj F; Rangasamy S; Anjana RM; Abhijit S; Gokulakrishnan K; Das A; Mohan V; Balasubramanyam M
J Diabetes Complications; 2017 May; 31(5):804-809. PubMed ID: 28336215
[TBL] [Abstract][Full Text] [Related]
14. Serum markers of oxidative stress and severity of diabetic retinopathy.
Hartnett ME; Stratton RD; Browne RW; Rosner BA; Lanham RJ; Armstrong D
Diabetes Care; 2000 Feb; 23(2):234-40. PubMed ID: 10868837
[TBL] [Abstract][Full Text] [Related]
15. Development of proliferative retinopathy in NIDDM. A follow-up study of American Indians in Oklahoma.
Lee ET; Lee VS; Lu M; Russell D
Diabetes; 1992 Mar; 41(3):359-67. PubMed ID: 1551496
[TBL] [Abstract][Full Text] [Related]
16. Heart rate elevation and diabetic retinopathy in patients with type 2 diabetes mellitus and normoalbuminuria.
Imano E; Miyatsuka T; Motomura M; Kanda T; Matsuhisa M; Kajimoto Y; Yamasaki Y; Hori M
Diabetes Res Clin Pract; 2001 Jun; 52(3):185-91. PubMed ID: 11323088
[TBL] [Abstract][Full Text] [Related]
17. Lean (underweight) NIDDM - peculiarities and differences in metabolic and hormonal status - a pilot study.
Das S; Samal KC; Baliarsinha AK; Tripathy BB
J Assoc Physicians India; 1995 May; 43(5):339-42. PubMed ID: 9081965
[TBL] [Abstract][Full Text] [Related]
18. Fibrinolysis and diabetic retinopathy in NIDDM.
Mansfield MW; Grant PJ
Diabetes Care; 1995 Dec; 18(12):1577-81. PubMed ID: 8722054
[TBL] [Abstract][Full Text] [Related]
19. Plasma t-PA and PAI-1 antigen concentrations in non-insulin dependent diabetic patients: implication for diabetic retinopathy.
Cho YW; Yang DH; Oh DY; Baick SH; Kim SK; Kim SJ; Hong SY
Diabetes Res Clin Pract; 1994 Jan; 22(2-3):123-8. PubMed ID: 8200293
[TBL] [Abstract][Full Text] [Related]
20. Residual beta-cell function and HLA-A24 in IDDM. Markers of glycemic control and subsequent development of diabetic retinopathy.
Nakanishi K; Kobayashi T; Inoko H; Tsuji K; Murase T; Kosaka K
Diabetes; 1995 Nov; 44(11):1334-9. PubMed ID: 7589833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
